Help
RSS
API
Feed
Maltego
Contact
Domain > drugs-porphyria.org
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2019-01-05
194.63.248.94
(
ClassC
)
2024-08-31
194.63.249.219
(
ClassC
)
2025-01-27
20.50.2.46
(
ClassC
)
Port 80
HTTP/1.1 200 OKServer: nginxDate: Sat, 31 Aug 2024 14:48:17 GMTContent-Type: text/html; charsetutf-8Content-Length: 4426Connection: keep-aliveVary: Accept-EncodingLast-Modified: Tue, 16 Jan 2024 11:23 !doctype html>html>head>meta charsetutf-8>title>..:: The Drug Database ::../title>link relicon typeimage/x-icon hrefimages/fav.ico>link relstylesheet hrefdp.css>/head>body classbodyback> div alignright>img srcimages/NAPOS.gif>/div> div aligncenter> br> br> br> br> h1>u>The drug database for acute porphyria/u>/h1> /div> div aligncenter> form actionindex2.php methodput> label forlang>Select language:/label> select namelang idlang> option data-fasstar valueGbr>English/option> option data-fasstar valueNor>Norwegian/option> option data-fasstar valueSwe>Swedish/option> option data-fasstar valueFra>French/option> /select> input typesubmit> /form> /div> div aligncenter> br> By using this website, we consider that you accept the following: br> br> br> br> textarea ideula nameeula rows14 cols120>Disclaimer, Terms of Use, and Copyright Notice for the Drug Database for Acute Porphyria Disclaimer:The Drug Database for Acute Porphyria is a property of The Norwegian Porphyria Centre (NAPOS). The information providedin this database is intended for use by healthcare professionals. While it may be of interest to patients, decisionsregarding drug use in acute porphyria should always be made in consultation with healthcare professionals. In cases ofuncertainty, additional advice should be sought. The database comprises expert assessments of the potential of drugs toprovoke porphyria attacks in patients with acute hepatic porphyria, including Acute Intermittent Porphyria (AIP),Variegate Porphyria (VP), Hereditary Coproporphyria (HCP), and ALA Dehydratase Deficiency Porphyria (ADP). It offersguidance based on a thorough evaluation of international clinical experience, published case reports, and theoreticalconsiderations. The information presented in this database, which involves some degree of uncertainty, serves asguidance to healthcare professionals. The Norwegian Porphyria Centre (NAPOS) accepts no responsibility for any errors,differences of opinion, or adverse consequences arising from the use
Port 443
HTTP/1.1 200 OKServer: nginxDate: Sat, 31 Aug 2024 14:48:18 GMTContent-Type: text/html; charsetutf-8Content-Length: 4426Connection: keep-aliveVary: Accept-EncodingLast-Modified: Tue, 16 Jan 2024 11:23 !doctype html>html>head>meta charsetutf-8>title>..:: The Drug Database ::../title>link relicon typeimage/x-icon hrefimages/fav.ico>link relstylesheet hrefdp.css>/head>body classbodyback> div alignright>img srcimages/NAPOS.gif>/div> div aligncenter> br> br> br> br> h1>u>The drug database for acute porphyria/u>/h1> /div> div aligncenter> form actionindex2.php methodput> label forlang>Select language:/label> select namelang idlang> option data-fasstar valueGbr>English/option> option data-fasstar valueNor>Norwegian/option> option data-fasstar valueSwe>Swedish/option> option data-fasstar valueFra>French/option> /select> input typesubmit> /form> /div> div aligncenter> br> By using this website, we consider that you accept the following: br> br> br> br> textarea ideula nameeula rows14 cols120>Disclaimer, Terms of Use, and Copyright Notice for the Drug Database for Acute Porphyria Disclaimer:The Drug Database for Acute Porphyria is a property of The Norwegian Porphyria Centre (NAPOS). The information providedin this database is intended for use by healthcare professionals. While it may be of interest to patients, decisionsregarding drug use in acute porphyria should always be made in consultation with healthcare professionals. In cases ofuncertainty, additional advice should be sought. The database comprises expert assessments of the potential of drugs toprovoke porphyria attacks in patients with acute hepatic porphyria, including Acute Intermittent Porphyria (AIP),Variegate Porphyria (VP), Hereditary Coproporphyria (HCP), and ALA Dehydratase Deficiency Porphyria (ADP). It offersguidance based on a thorough evaluation of international clinical experience, published case reports, and theoreticalconsiderations. The information presented in this database, which involves some degree of uncertainty, serves asguidance to healthcare professionals. The Norwegian Porphyria Centre (NAPOS) accepts no responsibility for any errors,differences of opinion, or adverse consequences arising from the use
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]